Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed a repurchase of 130,000 H-shares on 24 June 2026 via on-exchange transactions.
The shares were bought at prices ranging between HKD 3.13 and HKD 3.18, with a volume-weighted average of HKD 3.1538. Total consideration reached approximately HKD 0.41 million.
After the transaction: • Issued shares (excluding treasury shares) declined to 4.46 billion, down by 0.0029%. • Treasury shares increased to 59.96 million, keeping total issued shares unchanged at 4.52 billion.
The buy-back forms part of the mandate approved on 29 May 2026, which authorises repurchases of up to 446.46 million shares. To date, Weigao Group has repurchased 2.64 million shares, representing 0.591% of the company’s issued share capital at the mandate date.
Under Hong Kong listing rules, Weigao Group is restricted from issuing new shares or disposing of treasury shares until 24 July 2026.
Comments